Involvement of substance P in the development of cisplatin‐induced acute and delayed pica in rats

Background and Purpose Although substance P (SP) and neurokinin NK1 receptors have been reported to be involved in cisplatin‐induced acute and delayed emesis, their precise roles remain unclear. Pica, the consumption of non‐nutrient materials such as kaolin in rats, can be used as a model of nausea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 2014-06, Vol.171 (11), p.2888-2899
Hauptverfasser: Yamamoto, Kouichi, Asano, Keiko, Tasaka, Ayana, Ogura, Yuko, Kim, Seikou, Ito, Yui, Yamatodani, Atsushi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2899
container_issue 11
container_start_page 2888
container_title British journal of pharmacology
container_volume 171
creator Yamamoto, Kouichi
Asano, Keiko
Tasaka, Ayana
Ogura, Yuko
Kim, Seikou
Ito, Yui
Yamatodani, Atsushi
description Background and Purpose Although substance P (SP) and neurokinin NK1 receptors have been reported to be involved in cisplatin‐induced acute and delayed emesis, their precise roles remain unclear. Pica, the consumption of non‐nutrient materials such as kaolin in rats, can be used as a model of nausea in humans. We investigated the time‐dependent changes in cisplatin‐induced pica and the involvement of SP and NK1 receptors in this behaviour. Experimental Approach Rats were administered cisplatin with or without a daily injection of a 5‐HT3 receptor antagonist (granisetron) or an NK1 receptor antagonist (aprepitant), and kaolin intake was then monitored for 5 days. The effects of granisetron on the cisplatin‐induced expression of preprotachykinin‐A (PPT‐A) mRNA, which encodes mainly for SP, and on SP release in the medulla, measured by in vivo brain microdialysis, were also investigated. Key Results Cisplatin induced pica within 8 h of its administration that continued for 5 days. Granisetron inhibited the acute phase (day 1), but not the delayed phase (days 2–5), of pica, whereas aprepitant abolished both phases. Within 24 h of the injection of cisplatin, PPT‐A mRNA expression and SP release in the medulla were significantly increased; these findings lasted during the observation period and were inhibited by granisetron for up to 24 h. Conclusions and Implications The profiles of cisplatin‐induced pica in rats are similar to clinical findings for cisplatin‐induced emesis in humans, and we showed that SP production in the medulla and activation of NK1 receptors are involved in this cisplatin‐induced pica.
doi_str_mv 10.1111/bph.12629
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4243862</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3963169171</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5099-d82c95122f389624463a86602f9138f557f01d5add04236a2752f9844db5e8e03</originalsourceid><addsrcrecordid>eNp1kUFLwzAYhoMobk4P_gEpePLQLUmTNL0IOtQNBu6g55Alqcvo0tq0k938Cf5Gf4mZ20QP5vJB3ofn--AF4BzBPgpvMKvmfYQZzg5AF5GUxTTh6BB0IYRpjBDnHXDi_QLCEKb0GHQwYQSxDHeBGrtVWazM0rgmKvPItzPfSKdMNI2si5q5ibRZmaKs9oSyvipkY93n-4d1ulVGR1K1jYmk0wEu5Dr8VFbJjaCWjT8FR7ksvDnbzR54vr97Go7iyePDeHgziRWFWRZrjlVGEcZ5wjOGCWGJ5IxBnGco4TmlaQ6RplJrSHDCJE5piDghekYNNzDpgeutt2pnS6NVOLiWhahqu5T1WpTSir-Js3PxUq4EwSThDAfB5U5Ql6-t8Y1YlG3tws0CpSzNGIJss-ZqS6m69L42-c8GBMWmDxH6EN99BPbi90k_5L6AAAy2wJstzPp_k7idjrbKL-tslag</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1767961060</pqid></control><display><type>article</type><title>Involvement of substance P in the development of cisplatin‐induced acute and delayed pica in rats</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><source>Wiley Free Archive</source><source>PubMed (Medline)</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Yamamoto, Kouichi ; Asano, Keiko ; Tasaka, Ayana ; Ogura, Yuko ; Kim, Seikou ; Ito, Yui ; Yamatodani, Atsushi</creator><creatorcontrib>Yamamoto, Kouichi ; Asano, Keiko ; Tasaka, Ayana ; Ogura, Yuko ; Kim, Seikou ; Ito, Yui ; Yamatodani, Atsushi</creatorcontrib><description>Background and Purpose Although substance P (SP) and neurokinin NK1 receptors have been reported to be involved in cisplatin‐induced acute and delayed emesis, their precise roles remain unclear. Pica, the consumption of non‐nutrient materials such as kaolin in rats, can be used as a model of nausea in humans. We investigated the time‐dependent changes in cisplatin‐induced pica and the involvement of SP and NK1 receptors in this behaviour. Experimental Approach Rats were administered cisplatin with or without a daily injection of a 5‐HT3 receptor antagonist (granisetron) or an NK1 receptor antagonist (aprepitant), and kaolin intake was then monitored for 5 days. The effects of granisetron on the cisplatin‐induced expression of preprotachykinin‐A (PPT‐A) mRNA, which encodes mainly for SP, and on SP release in the medulla, measured by in vivo brain microdialysis, were also investigated. Key Results Cisplatin induced pica within 8 h of its administration that continued for 5 days. Granisetron inhibited the acute phase (day 1), but not the delayed phase (days 2–5), of pica, whereas aprepitant abolished both phases. Within 24 h of the injection of cisplatin, PPT‐A mRNA expression and SP release in the medulla were significantly increased; these findings lasted during the observation period and were inhibited by granisetron for up to 24 h. Conclusions and Implications The profiles of cisplatin‐induced pica in rats are similar to clinical findings for cisplatin‐induced emesis in humans, and we showed that SP production in the medulla and activation of NK1 receptors are involved in this cisplatin‐induced pica.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/bph.12629</identifier><identifier>PMID: 24641692</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>5‐HT3 receptor ; acute emesis ; Animals ; Antiemetics - pharmacology ; Antineoplastic Agents ; brain microdialysis ; Cisplatin ; delayed emesis ; Eating ; Granisetron - pharmacology ; Kaolin - administration &amp; dosage ; Male ; medulla ; Medulla Oblongata - drug effects ; Medulla Oblongata - metabolism ; Morpholines - pharmacology ; Nausea - chemically induced ; Nausea - metabolism ; neurokinin NK1 receptor ; Neurokinin-1 Receptor Antagonists - pharmacology ; pica ; Pica - chemically induced ; Pica - metabolism ; preprotachykinin‐A ; Protein Precursors - genetics ; Rats, Wistar ; Receptors, Neurokinin-1 - metabolism ; Receptors, Serotonin, 5-HT3 - metabolism ; Research Papers ; RNA, Messenger - metabolism ; Rodents ; Serotonin Antagonists - pharmacology ; Solitary Nucleus - drug effects ; Solitary Nucleus - metabolism ; substance P ; Substance P - metabolism ; Tachykinins - genetics</subject><ispartof>British journal of pharmacology, 2014-06, Vol.171 (11), p.2888-2899</ispartof><rights>2014 The British Pharmacological Society</rights><rights>2014 The British Pharmacological Society.</rights><rights>Copyright © 2014 The British Pharmacological Society</rights><rights>2014 The British Pharmacological Society 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5099-d82c95122f389624463a86602f9138f557f01d5add04236a2752f9844db5e8e03</citedby><cites>FETCH-LOGICAL-c5099-d82c95122f389624463a86602f9138f557f01d5add04236a2752f9844db5e8e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243862/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243862/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1417,1433,27924,27925,45574,45575,46409,46833,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24641692$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamamoto, Kouichi</creatorcontrib><creatorcontrib>Asano, Keiko</creatorcontrib><creatorcontrib>Tasaka, Ayana</creatorcontrib><creatorcontrib>Ogura, Yuko</creatorcontrib><creatorcontrib>Kim, Seikou</creatorcontrib><creatorcontrib>Ito, Yui</creatorcontrib><creatorcontrib>Yamatodani, Atsushi</creatorcontrib><title>Involvement of substance P in the development of cisplatin‐induced acute and delayed pica in rats</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>Background and Purpose Although substance P (SP) and neurokinin NK1 receptors have been reported to be involved in cisplatin‐induced acute and delayed emesis, their precise roles remain unclear. Pica, the consumption of non‐nutrient materials such as kaolin in rats, can be used as a model of nausea in humans. We investigated the time‐dependent changes in cisplatin‐induced pica and the involvement of SP and NK1 receptors in this behaviour. Experimental Approach Rats were administered cisplatin with or without a daily injection of a 5‐HT3 receptor antagonist (granisetron) or an NK1 receptor antagonist (aprepitant), and kaolin intake was then monitored for 5 days. The effects of granisetron on the cisplatin‐induced expression of preprotachykinin‐A (PPT‐A) mRNA, which encodes mainly for SP, and on SP release in the medulla, measured by in vivo brain microdialysis, were also investigated. Key Results Cisplatin induced pica within 8 h of its administration that continued for 5 days. Granisetron inhibited the acute phase (day 1), but not the delayed phase (days 2–5), of pica, whereas aprepitant abolished both phases. Within 24 h of the injection of cisplatin, PPT‐A mRNA expression and SP release in the medulla were significantly increased; these findings lasted during the observation period and were inhibited by granisetron for up to 24 h. Conclusions and Implications The profiles of cisplatin‐induced pica in rats are similar to clinical findings for cisplatin‐induced emesis in humans, and we showed that SP production in the medulla and activation of NK1 receptors are involved in this cisplatin‐induced pica.</description><subject>5‐HT3 receptor</subject><subject>acute emesis</subject><subject>Animals</subject><subject>Antiemetics - pharmacology</subject><subject>Antineoplastic Agents</subject><subject>brain microdialysis</subject><subject>Cisplatin</subject><subject>delayed emesis</subject><subject>Eating</subject><subject>Granisetron - pharmacology</subject><subject>Kaolin - administration &amp; dosage</subject><subject>Male</subject><subject>medulla</subject><subject>Medulla Oblongata - drug effects</subject><subject>Medulla Oblongata - metabolism</subject><subject>Morpholines - pharmacology</subject><subject>Nausea - chemically induced</subject><subject>Nausea - metabolism</subject><subject>neurokinin NK1 receptor</subject><subject>Neurokinin-1 Receptor Antagonists - pharmacology</subject><subject>pica</subject><subject>Pica - chemically induced</subject><subject>Pica - metabolism</subject><subject>preprotachykinin‐A</subject><subject>Protein Precursors - genetics</subject><subject>Rats, Wistar</subject><subject>Receptors, Neurokinin-1 - metabolism</subject><subject>Receptors, Serotonin, 5-HT3 - metabolism</subject><subject>Research Papers</subject><subject>RNA, Messenger - metabolism</subject><subject>Rodents</subject><subject>Serotonin Antagonists - pharmacology</subject><subject>Solitary Nucleus - drug effects</subject><subject>Solitary Nucleus - metabolism</subject><subject>substance P</subject><subject>Substance P - metabolism</subject><subject>Tachykinins - genetics</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUFLwzAYhoMobk4P_gEpePLQLUmTNL0IOtQNBu6g55Alqcvo0tq0k938Cf5Gf4mZ20QP5vJB3ofn--AF4BzBPgpvMKvmfYQZzg5AF5GUxTTh6BB0IYRpjBDnHXDi_QLCEKb0GHQwYQSxDHeBGrtVWazM0rgmKvPItzPfSKdMNI2si5q5ibRZmaKs9oSyvipkY93n-4d1ulVGR1K1jYmk0wEu5Dr8VFbJjaCWjT8FR7ksvDnbzR54vr97Go7iyePDeHgziRWFWRZrjlVGEcZ5wjOGCWGJ5IxBnGco4TmlaQ6RplJrSHDCJE5piDghekYNNzDpgeutt2pnS6NVOLiWhahqu5T1WpTSir-Js3PxUq4EwSThDAfB5U5Ql6-t8Y1YlG3tws0CpSzNGIJss-ZqS6m69L42-c8GBMWmDxH6EN99BPbi90k_5L6AAAy2wJstzPp_k7idjrbKL-tslag</recordid><startdate>201406</startdate><enddate>201406</enddate><creator>Yamamoto, Kouichi</creator><creator>Asano, Keiko</creator><creator>Tasaka, Ayana</creator><creator>Ogura, Yuko</creator><creator>Kim, Seikou</creator><creator>Ito, Yui</creator><creator>Yamatodani, Atsushi</creator><general>Blackwell Publishing Ltd</general><general>BlackWell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>5PM</scope></search><sort><creationdate>201406</creationdate><title>Involvement of substance P in the development of cisplatin‐induced acute and delayed pica in rats</title><author>Yamamoto, Kouichi ; Asano, Keiko ; Tasaka, Ayana ; Ogura, Yuko ; Kim, Seikou ; Ito, Yui ; Yamatodani, Atsushi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5099-d82c95122f389624463a86602f9138f557f01d5add04236a2752f9844db5e8e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>5‐HT3 receptor</topic><topic>acute emesis</topic><topic>Animals</topic><topic>Antiemetics - pharmacology</topic><topic>Antineoplastic Agents</topic><topic>brain microdialysis</topic><topic>Cisplatin</topic><topic>delayed emesis</topic><topic>Eating</topic><topic>Granisetron - pharmacology</topic><topic>Kaolin - administration &amp; dosage</topic><topic>Male</topic><topic>medulla</topic><topic>Medulla Oblongata - drug effects</topic><topic>Medulla Oblongata - metabolism</topic><topic>Morpholines - pharmacology</topic><topic>Nausea - chemically induced</topic><topic>Nausea - metabolism</topic><topic>neurokinin NK1 receptor</topic><topic>Neurokinin-1 Receptor Antagonists - pharmacology</topic><topic>pica</topic><topic>Pica - chemically induced</topic><topic>Pica - metabolism</topic><topic>preprotachykinin‐A</topic><topic>Protein Precursors - genetics</topic><topic>Rats, Wistar</topic><topic>Receptors, Neurokinin-1 - metabolism</topic><topic>Receptors, Serotonin, 5-HT3 - metabolism</topic><topic>Research Papers</topic><topic>RNA, Messenger - metabolism</topic><topic>Rodents</topic><topic>Serotonin Antagonists - pharmacology</topic><topic>Solitary Nucleus - drug effects</topic><topic>Solitary Nucleus - metabolism</topic><topic>substance P</topic><topic>Substance P - metabolism</topic><topic>Tachykinins - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamamoto, Kouichi</creatorcontrib><creatorcontrib>Asano, Keiko</creatorcontrib><creatorcontrib>Tasaka, Ayana</creatorcontrib><creatorcontrib>Ogura, Yuko</creatorcontrib><creatorcontrib>Kim, Seikou</creatorcontrib><creatorcontrib>Ito, Yui</creatorcontrib><creatorcontrib>Yamatodani, Atsushi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamamoto, Kouichi</au><au>Asano, Keiko</au><au>Tasaka, Ayana</au><au>Ogura, Yuko</au><au>Kim, Seikou</au><au>Ito, Yui</au><au>Yamatodani, Atsushi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Involvement of substance P in the development of cisplatin‐induced acute and delayed pica in rats</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2014-06</date><risdate>2014</risdate><volume>171</volume><issue>11</issue><spage>2888</spage><epage>2899</epage><pages>2888-2899</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>Background and Purpose Although substance P (SP) and neurokinin NK1 receptors have been reported to be involved in cisplatin‐induced acute and delayed emesis, their precise roles remain unclear. Pica, the consumption of non‐nutrient materials such as kaolin in rats, can be used as a model of nausea in humans. We investigated the time‐dependent changes in cisplatin‐induced pica and the involvement of SP and NK1 receptors in this behaviour. Experimental Approach Rats were administered cisplatin with or without a daily injection of a 5‐HT3 receptor antagonist (granisetron) or an NK1 receptor antagonist (aprepitant), and kaolin intake was then monitored for 5 days. The effects of granisetron on the cisplatin‐induced expression of preprotachykinin‐A (PPT‐A) mRNA, which encodes mainly for SP, and on SP release in the medulla, measured by in vivo brain microdialysis, were also investigated. Key Results Cisplatin induced pica within 8 h of its administration that continued for 5 days. Granisetron inhibited the acute phase (day 1), but not the delayed phase (days 2–5), of pica, whereas aprepitant abolished both phases. Within 24 h of the injection of cisplatin, PPT‐A mRNA expression and SP release in the medulla were significantly increased; these findings lasted during the observation period and were inhibited by granisetron for up to 24 h. Conclusions and Implications The profiles of cisplatin‐induced pica in rats are similar to clinical findings for cisplatin‐induced emesis in humans, and we showed that SP production in the medulla and activation of NK1 receptors are involved in this cisplatin‐induced pica.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>24641692</pmid><doi>10.1111/bph.12629</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2014-06, Vol.171 (11), p.2888-2899
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4243862
source Wiley-Blackwell Journals; MEDLINE; Wiley Free Archive; PubMed (Medline); Alma/SFX Local Collection; EZB Electronic Journals Library
subjects 5‐HT3 receptor
acute emesis
Animals
Antiemetics - pharmacology
Antineoplastic Agents
brain microdialysis
Cisplatin
delayed emesis
Eating
Granisetron - pharmacology
Kaolin - administration & dosage
Male
medulla
Medulla Oblongata - drug effects
Medulla Oblongata - metabolism
Morpholines - pharmacology
Nausea - chemically induced
Nausea - metabolism
neurokinin NK1 receptor
Neurokinin-1 Receptor Antagonists - pharmacology
pica
Pica - chemically induced
Pica - metabolism
preprotachykinin‐A
Protein Precursors - genetics
Rats, Wistar
Receptors, Neurokinin-1 - metabolism
Receptors, Serotonin, 5-HT3 - metabolism
Research Papers
RNA, Messenger - metabolism
Rodents
Serotonin Antagonists - pharmacology
Solitary Nucleus - drug effects
Solitary Nucleus - metabolism
substance P
Substance P - metabolism
Tachykinins - genetics
title Involvement of substance P in the development of cisplatin‐induced acute and delayed pica in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A52%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Involvement%20of%20substance%20P%20in%20the%20development%20of%20cisplatin%E2%80%90induced%20acute%20and%20delayed%20pica%20in%20rats&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Yamamoto,%20Kouichi&rft.date=2014-06&rft.volume=171&rft.issue=11&rft.spage=2888&rft.epage=2899&rft.pages=2888-2899&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1111/bph.12629&rft_dat=%3Cproquest_pubme%3E3963169171%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1767961060&rft_id=info:pmid/24641692&rfr_iscdi=true